MONMOUTH JUNCTION, N.J., Oct. 5, 2020 /PRNewswire/ — DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Dr. Kira Sheinerman, Chief Executive Officer, will be presenting and participating in a panel discussion at The 21st International Conference on Alzheimer’s Drug Discovery hosted by the Alzheimer’s Drug Discovery Foundation (ADDF) and held virtually October 5-6, 2020.